Om Prakash Manchanda, CEO, Dr. Lal PathLabs, recently made a cool Rs 11.8 crore by selling 100,000 shares from his personal holding. Post the transaction, Manchanda’s stake is down to 0.85% from 0.97%.
The diagnostic chain operator not only saw its IPO oversubscribed 33x in December, 2015, it has also seen continued interest in the secondary market. In 2016, the stock is up 47%. In fact, over the past month, it has gained about 13% as investors price in the increased revenue due to the dengu